Jon Levine

Cannabis Rescheduling Likely 'In The Next 12 Months,' Says MariMed CEO As Company Invests In Key Markets
MariMed Revenue Grows 10.7% QoQ, Hires New CFO And Remains On Track To Deliver 2024 Financial Targets
Cannabis Cultivation Solutions Provider Agrify And California's Nature's Miracle Sign Definitive Merger Deal
MariMed Revenue Grows 10.7% QoQ, Hires New CFO And Remains On Track To Deliver 2024 Financial Targets
Cannabis Cultivation Solutions Provider Agrify And California's Nature's Miracle Sign Definitive Merger Deal
Q1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross Margin
MariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis Dispensary

Jon Levine Recent News

How Did MariMed Cannabis Company's Revenue Surge By 48%? Find Out At Benzinga Cannabis Capital Conference
MariMed, Inc. has embarked on a remarkable journey, boasting a 48% increase in wholesale revenue in 2023 and projecting over 20% growth for 2024. Under the leadership of CEO Jon Levine, the company has navigated through regulatory uncertainties and competitive market headwinds with strategic expansions and product innovation.
Top Cannabis Industry Leaders Who Took The Reins In 2023
EXCLUSIVE: MariMed CEO Discusses Evolving Illinois Cannabis Market, Rescheduling
Jon Levine, CEO of multi-state cannabis operator, MariMed (OTC: MRMD), and Erik Sloane, Global Head of Corporate Listings at Cboe Canada, discussed the evolving Illinois cannabis market at the
MariMed Q2 FY23 Revenue Grows 10.7% YoY, What About Adjusted EBITDA?
MariMed Inc. (OTC: MRMD) (CSE:MRMD) released its financial results for the second quarter ended June 30, 2023, revealing revenue of $36.5 million, an increase of 10.7% compared to $33 million in Q2 2022. Q2 2023 Financial Highlights
MariMed Stages The 'Boston 280E THC Party' In Protest Of 'An Unfair Tax That Burdens The Cannabis Industry'
Channeling the Boston Tea Party’s rebellious spirit while dressed in traditional colonial garb, MariMed (OTCQX: MRMD) (CSE:MRMD) executives and team members staged the ‘Boston 280E THC Party’ from a boat in Boston Harbor on July 12.
How To Create Loyal Customers Not Because They Don't Have Other Options, But Because They Do
Marijuana’s status as a Schedule 1 substance under federal law makes things far more complicated for this industry compared to others. Despite 23 states having legalized recreational cannabis use and 39 with medical marijuana programs, one of the biggest challenges to the industry is the glaring lack of financial services.
MariMed Reports Earnings: Q1 Revenue Falls 4% Sequentially, CEO Pleased With 'Solid Quarter'
MariMed, Inc (CSE: MRMD) (OTCQX: MRMD) announced its financial results late Monday for the first quarter ended March 31, 2023.
EXCLUSIVE: 'Beat The Crap Out Of The Competition' And Other Cannabis Industry Secrets To Success
The marijuana industry continues to face challenges with restricted financing options. But several titans in the space gathered on stage at the 2023 Benzinga Cannabis Capital Conference in Miami to offer suggestions on how to maintain growth.
Interested In Cannabis Industry Growth Trends? CEO Of Weed Distribution Giant Eaze Has Some Insights
The Benzinga Cannabis Capital Conference, the world's largest gathering of cannabis decision-makers, founders, investors and advocates is returning to Miami Beach, Florida on April 11-12, 2023 and Eaze's CEO Cory Azzalino will be there to share his insights into where industr
Latest Executive Changes In Marijuana Industry, New Appointments & More
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari
2023 Off To A Busy Start: Top Cannabis Execs Making Moves, Will They Attend Benzinga's April Event?
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through some executive moves from the first two mon
Acquisitions & Expansion Boost Marimed's Q4 Revenue 6% Sequentially, 2022 Sales Increased To $134M
MariMed, Inc. (OTCQX: MRMD) announced its financial results Wednesday afternoon for the fourth quarter and full year ended December 31, 2022. The company reported sales for the year increased to $134 million, compared with $121.5 million the prior year.
Key Marijuana Executive Changes You Should Know About: Award-Winning TV Personality Joins MMJ Start-Up & More News
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders
Cannabis Company MariMed Closes $35M Credit Facility To Boost Strategic Growth Plans
MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator, announced it closed a $35 million secured credit facility with Chicago Atlantic Advisors, LLC as the lead lender.
Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down
MJBiz CEO To Step Down Marijuana Business Daily's Chris Walsh will step down as CEO in January.
MariMed's Q3 Financial Results, Revenue Increases 3% Sequentially To $33.9M
MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, recently announced its financial results for the third quarter that ended September 30, 2022.
EXCLUSIVE: How To Conquer The Midwest? 4Front, Pharmacann & Marimed Execs Discuss At Benzinga Cannabis Conference
Jon Levine, president of Marimed Inc., Brett Novey, CEO of Pharmacann and Andrew Thut, CIO of 4Front Ventures, operators in the Midwest and across the country, joined Barbara Webb, partner of MGO, and Steve Miles, CEO of Sharp Capi
MariMed Appoints Jon Levine As President
MariMed, Inc. (CSE:MRMD), (OTCQX: MRMD) appointed Jon Levine as president.
MariMed Reports Strong Q1, Provides 2022 Financial Guidance
MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2022.
EXCLUSIVE: Lessons Learned At The Benzinga 2022 Psychedelics And Cannabis Capital Conferences
Benzinga, a large content provider to brokerages and news outlets, hosts live conferences to recognize disruptive innovation in finance and technology, trading, and emerging assets.
MariMed Becomes Vertically-Integrated In Illinois Via Green Growth Acquisition
Cannabis company MariMed, Inc. (OTCQX: MRMD) announced Tuesday that it has inked a definitive agreement to acquire Green Growth Group. Terms of the deal to purchase the holder of a provisional cannabis craft license in Illinois were not disclosed.
MariMed: 213% YoY Increase In Q3 Adjusted EBITDA, Reaffirms Full-Year Revenue Guidance Of $118M
Multi-state cannabis operator MariMed, Inc. (OTCQX: MRMD) reported its financial and operating results Monday for the quarter ended September 30.
MariMed Posts Record Q1 2021 Results, Revenue Spikes 230%, EBITDA Up By 764% YoY
MariMed, Inc. (OTCQX: MRMD) disclosed Monday its core revenue spiked 230% year-over-year, reaching $24.6 million in the first quarter of 2021, marking it the company's highest-ever quarter of core cannabis revenue and profitability.